Straight from Stockholm: Randy Schekman, Ph.D., and James Rothman, Ph.D., will speak at ASCB in New Orleans after receiving the 2013 Nobel Prize in Physiology or Medicine.
Over 100 scientific sessions and 2,500 poster presentations about the latest research on cellular machines, the dynamic genome, translational medicine, cancer cell biology, cell interactions and the proverbial much, much more. (Please see examples below.)
Presidential Keynote Speakers Elaine Fuchs, Ph.D., whose topic will be, "Stems Cells in Homeostasis: Wound Repair and Cancer," and J. Craig Venter, Ph.D., who will speak about, "Life at the Speed of Light."
An inhibitor of tumor-associated macrophages is now under clinical evaluation after it effectively blocked progression of lethal brain tumors in lab animals.
Nicotine, the major addictive substance in cigarette smoke, contributes to smokers' higher risk of developing atherosclerosis. Results suggest that nicotine administration via e-cigarettes may not lower smokers' risk for heart disease.
Healing of chronically infected wounds can be expedited by inhibiting build-up of reactive oxygen species under the biofilms that develop in foot ulcers and other skin lesions that are difficult-to-treat and that account for the majority of limb amputations in the U.S.
Altering glucose levels and metabolism in mammalian cells can control influenza A infection.
Newly identified brain signaling axis provides potential early biomarkers and therapeutic targets for Alzheimer's disease.
Suppressing the enzyme fidgetin encourages injured axons of adult neurons to regenerate.
High-resolution imaging reveals how the Golgi disassembles and reassembles during cell division.
Overworked cellular machines help explain Gaucher disease-affected patients' predisposition to Parkinson's disease.
ONLINE PRESS REGISTRATION: http://am.
STUCK IN YOUR OFFICE during the ASCB annual meeting? Fire up your smart phone or computer and let the ASCB newsroom staff connect you to the scientists presenting these and other advances in cell biology.
FOR MORE INFORMATION, contact:
John Fleischman (ASCB staff)